Anxiety and Depression Are Related to Higher Activity of Sphingolipid Metabolizing Enzymes in the Rat Brain
Year: 2020
Type: article
Abstract: Changes in sphingolipid metabolism have been suggested to contribute to the pathophysiology of major depression. In this study, we investigated the activity of acid and neutral sphingomyelinases (ASM, NSM) and ceramidases (AC, NC), respectively, in twelve brain regions of female rats selectively bred for high (HAB) versus low (LAB) anxiety-like behavior. Concomitant with their highly anxious and depressive-like phenotype, HAB rats showed increased activity of ASM and NSM as well as of AC and NC in multiple brain regions associated with anxiety- and depressive-like behavior, including the lateral septum, hypothalamus, ventral hippocampus, ventral and dorsal mesencephalon. Strong correlations between anxiety-like behavior and ASM activity were found in female HAB rats in the amygdala, ventral hippocampus and dorsal mesencephalon, whereas NSM activity correlated with anxiety levels in the dorsal mesencephalon. These results provide novel information about the sphingolipid metabolism, especially about the sphingomyelinases and ceramidases, in major depression and comorbid anxiety.
Source: Cells
DOI: 10.3390/cells9051239
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,826
Awards: G1335218266, G2808949911, G3455270085, G4064564568, G4166355878, G4572534112, G474707634, G5188208403, GRK 2162: Entwicklung und Vulnerabilität des Zentralnervensystems, Verbund OptiMD im Forschungsnetz psychische Erkrankungen: Die Rolle des ASM/Ceramid-Systems bei Majorer Depression (Rattenmodelle und klinische Proben) (SP2a), Verbund OptiMD im Forschungsnetz psychische Erkrankungen: Identifizierung und Validierung von neuen Zielstrukturen des Gehirns für antidepressive Pharmaka in geeigneten Tiermodellen
OpenAlex ID: W3024852182
